funiculosin (anthraquinone) has been researched along with Liver Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DASDIA, T; DIMARCO, A; GAETANI, M; OREZZI, P; SCARPINATO, BM; SILVESTRINI, R; SOLDATI, M; VALENTINI, L | 1 |
1 other study(ies) available for funiculosin (anthraquinone) and Liver Neoplasms
| Article | Year |
|---|---|
'DAUNOMYCIN', A NEW ANTIBIOTIC OF THE RHODOMYCIN GROUP.
Topics: Animals; Anthracyclines; Anti-Bacterial Agents; Antimetabolites; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Daunorubicin; DNA; DNA, Neoplasm; Glycosides; Liver Neoplasms; Mice; Pharmacology; Polarography; Rats; Research; RNA; RNA, Neoplasm; Ultraviolet Rays | 1964 |